On January 24, 2024, the Supreme Court granted certiorari in Laboratory Corp. of America v. Davis (“LabCorp”),[1] to consider “[w]hether a federal court may certify a class action pursuant to Federal Rule of Civil Procedure 23(b)(3) when some members of the proposed class lack any Article III injury.” This will be the first time that the Supreme Court has addressed Article III standing requirements in class actions since deciding TransUnion LLC v. Ramirez in 2021.
Read the full blog post.